Publication | Open Access

Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study

Hematological MalignancyNeuro-oncologyDose-densified ChemoimmunotherapyLymphoid NeoplasiaOncologyImmunologyHematologyImmunotherapyMedicineLymphoma Patients